⌘K

Login Start Free

Home/Filings/4/0001645113-21-000081

4//SEC Filing

LEUNG GABRIEL 4

Accession 0001645113-21-000081

CIK 0001645113other

View on SEC.gov Company Profile

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 5:23 PM ET

Size

8.2 KB

Accession

0001645113-21-000081

Insider Transaction Report

Form 4

Period: 2021-07-06

NovoCure LtdNVCR

Director

Transactions

Exercise/Conversion
Ordinary Shares
2021-07-06$31.45/sh+1,000$31,450→ 73,859 total
Exercise/Conversion
Options to Buy Ordinary Shares
2021-07-06−1,000→ 3,345 total
Exercise: $31.45Exp: 2028-05-30→ Ordinary Shares (1,000 underlying)
Sale
Ordinary Shares
2021-07-06$183.54/sh−1,000$183,540→ 72,859 total

Footnotes (2)

[F1]Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
[F2]Fully vested as of the date hereof.

Documents

1 file

4
wf-form4_162577940551935.xmlPrimary
FORM 4

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1

filerCIK 0001236183

Filing Metadata

Form type: 4
Filed: Jul 7, 8:00 PM ET
Accepted: Jul 8, 5:23 PM ET
Size: 8.2 KB

View on SEC.gov